Merck’s COVID-19 Drug Fails to Show ‘Statistically Significant Reduction’ in Infection Risk

February 22, 2023

Merck’s COVID-19 Antiviral Drug Doesn’t Reduce Hospitalization or Death in High-Risk Vaccinated People: Study

December 26, 2022

FDA Says Found Possible Carcinogen in Certain Samples of Merck’s Januvia!

August 11, 2022

Merck Raises 2022 Forecast As COVID Pill, Cancer Drug Fuels Profit Beat.

April 30, 2022